Hims & Hers Health/$HIMS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hims & Hers Health
Hims & Hers Health Inc operates telehealth platforms, providing access to treatments for various chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. The company connects patients to licensed healthcare professionals who can prescribe medications, with prescriptions fulfilled online through licensed pharmacies. In addition, it offers access to various non-prescription health and wellness products. Through the Hims & Hers mobile applications, the company also offers access to educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Geographically, it derives maximum revenue from the USA.
Ticker
$HIMS
Sector
Primary listing
NYSE
Employees
2,442
Headquarters
Website
HIMS Metrics
BasicAdvanced
$5B
42.98
$0.51
2.61
-
Price and volume
Market cap
$5B
Beta
2.61
52-week high
$70.43
52-week low
$13.74
Average daily volume
48M
Financial strength
Current ratio
1.898
Quick ratio
1.507
Long term debt to equity
206.265
Total debt to equity
207.161
Interest coverage (TTM)
31.07%
Profitability
EBITDA (TTM)
175.659
Gross margin (TTM)
73.84%
Net profit margin (TTM)
5.47%
Operating margin (TTM)
5.16%
Effective tax rate (TTM)
-3.58%
Revenue per employee (TTM)
$960,000
Management effectiveness
Return on assets (TTM)
5.29%
Return on equity (TTM)
25.23%
Valuation
Price to earnings (TTM)
42.984
Price to revenue (TTM)
2.11
Price to book
9.25
Price to tangible book (TTM)
75.26
Price to free cash flow (TTM)
86.277
Free cash flow yield (TTM)
1.16%
Free cash flow per share (TTM)
0.255
Growth
Revenue change (TTM)
59.00%
Earnings per share change (TTM)
-3.75%
3-year revenue growth (CAGR)
64.55%
3-year earnings per share growth (CAGR)
16.84%
What the Analysts think about HIMS
Analyst ratings (Buy, Hold, Sell) for Hims & Hers Health stock.
HIMS Financial Performance
Revenues and expenses
HIMS Earnings Performance
Company profitability
HIMS News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Hims & Hers Health stock?
Hims & Hers Health (HIMS) has a market cap of $5B as of March 23, 2026.
What is the P/E ratio for Hims & Hers Health stock?
The price to earnings (P/E) ratio for Hims & Hers Health (HIMS) stock is 42.98 as of March 23, 2026.
Does Hims & Hers Health stock pay dividends?
No, Hims & Hers Health (HIMS) stock does not pay dividends to its shareholders as of March 23, 2026.
When is the next Hims & Hers Health dividend payment date?
Hims & Hers Health (HIMS) stock does not pay dividends to its shareholders.
What is the beta indicator for Hims & Hers Health?
Hims & Hers Health (HIMS) has a beta rating of 2.61. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.